Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
108: An all-star panel discuss EIS & VCTs in 2024 and look forward to 2025
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can be accessed for free under MIFID.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
City of London Investment Group
Financials
Market recovery boosts FUM
By
Dr Brian Moretta
21 Jul 2020
Arbuthnot Banking Group Plc
Financials
2020 interim results: credit robust, rate sensitivity
By
Mark Thomas
20 Jul 2020
Stay up-to-date with the latest research
Sign up to our newsletter
Allergy Therapeutics plc
Life Sciences
Record sales and a COVID-19 wildcard
By
Dr Martin Hall
20 Jul 2020
Palace Capital
Property
Encouraging full-year results
By
Mike Foster
14 Jul 2020
Yew Grove REIT plc
Property
Strong strategy, tenants and total returns
By
Mike Foster
13 Jul 2020
Non-Standard Finance
Financials
FY’19 solid; outlook – broad range of outcomes
By
Mark Thomas
13 Jul 2020
ICG Enterprise Trust
Financials
Outperformance through every stage of cycle
By
Mark Thomas
06 Jul 2020
Advanced Oncotherapy
Life Sciences
Funded through to clinical events
By
Dr Martin Hall
02 Jul 2020
The Monthly: July 2020
01 Jul 2020
Bank North
Financials
Bridge over troubled waters
By
Mark Thomas
22 Jun 2020
Incanthera Ltd
Life Sciences
Preparing Sol for commercialisation
By
Dr Martin Hall
19 Jun 2020
Prev
1
...
36
37
38
39
40
...
78
Next
